Briacell Therapeutics Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$4.18

+0.10 (+2.45%)

As of May 16, 2:23 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +492.1% upside

Low Target $18.09

Average Target $24.75

High Target $34.06

Current Price $4.18

Current
$4.18

Target
$24.75

$18.09 $24.75 avg $34.06

Scenario Analysis

Bear Case

$18.09

332.8%

Low target

Base Case

$24.75

+492.1%

Avg target

Bull Case

$34.06

+714.8%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$51.50

-91.9% from high

52-Week Low

$4.95

+-15.6% from low

Target vs 52W High

$24.75

-51.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%